Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.

Abstract

The European Group for Blood and Marrow Transplantation (EBMT) devised a scoring system to predict survival after allogeneic haematopoietic stem cell transplantation (HSCT) for chronic myeloid leukaemia (CML). The present International Bone Marrow Transplant Registry study of 3211 patients tested the EBMT Risk Score in a independent population, investigated… (More)

Topics

Cite this paper

@article{Passweg2004ValidationAE, title={Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.}, author={Jakob Robert Passweg and Irwin Walker and Kathleen A. Sobocinski and John P. Klein and Mary Horowitz and Sergio A. Giralt}, journal={British journal of haematology}, year={2004}, volume={125 5}, pages={613-20} }